25
edits
Transfusion Medicine Department Information: Difference between revisions
Transfusion Medicine Department Information (view source)
Revision as of 00:04, 23 September 2026
, Yesterday at 00:04no edit summary
(→) |
No edit summary |
||
| Line 177: | Line 177: | ||
'''*Approval to Treat with Immunoglobulins''' | '''*Approval to Treat with Immunoglobulins''' | ||
Approval to access intravenous immunoglobulin (IVIg) or subcutaneous immunoglobulin (SCIg) is required. The approval quantifies dose, product type, frequency and when a clinical review is indicated | Approval to access intravenous immunoglobulin (IVIg) or subcutaneous immunoglobulin (SCIg) is required - the Blood Bank can be contacted to determine whether there is a current approval. | ||
The approval quantifies dose, product type, frequency and when a clinical review is indicated, and is managed electronically through the [https://igo.nzblood.co.nz/Security/login NZBS Immunoglobulins Online Approval Portal - IgO]. Registrars or consultants can register with IgO using a hospital email account, which can take up to 24 hours. If the product is required in an emergency situation and cannot wait for an IgO account to be created, it can be requested by forwarding a completed [https://www.nzblood.co.nz/assets/Transfusion-Medicine/PDFs/111F075.pdf Approval for Immunoglobulin] form to the Blood Bank. | |||
=== '''Transfusion Therapy''' === | === '''Transfusion Therapy''' === | ||